Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

Clinical trial NCT06914479 · RECRUITING

Trial details

NCT number

NCT06914479

Sponsor

University of Michigan Rogel Cancer Center

Status

RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2026-05-22

Primary completion

2031-05-01

Enrollment

11

View on ClinicalTrials.gov